1.50
-0.08(-5.06%)
Currency In USD
| Previous Close | 1.58 |
| Open | 1.59 |
| Day High | 1.59 |
| Day Low | 1.48 |
| 52-Week High | 1.91 |
| 52-Week Low | 0.61 |
| Volume | 113,762 |
| Average Volume | 244,682 |
| Market Cap | 82.78M |
| PE | -0.91 |
| EPS | -1.64 |
| Moving Average 50 Days | 1.24 |
| Moving Average 200 Days | 0.97 |
| Change | -0.08 |
If you invested $1000 in Prelude Therapeutics Incorporated (PRLD) since IPO date, it would be worth $57.25 as of October 24, 2025 at a share price of $1.5. Whereas If you bought $1000 worth of Prelude Therapeutics Incorporated (PRLD) shares 3 years ago, it would be worth $226.24 as of October 24, 2025 at a share price of $1.5.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors
GlobeNewswire Inc.
Oct 17, 2025 11:30 AM GMT
WILMINGTON, Del., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the appointment of Katina Dorton to its Board of Directors, effective today. Ms. Dor
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
GlobeNewswire Inc.
Jun 02, 2025 11:30 AM GMT
WILMINGTON, Del., June 02, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in
Prelude Therapeutics to Participate in Citizens Life Sciences Conference
GlobeNewswire Inc.
May 01, 2025 11:30 AM GMT
WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens Life Sciences Conference t